BLOOMBERG: Teva to Buy Allergan's Generics Business for $40.5B

Teva Pharmaceuticals is buying Allergan Plc's generic-drug business in a $40.5 billion deal and has also withdrawn its proposal to purchase Mylan. Bloomberg's Ryan Chilcote reports on "The Pulse."